TGFB1 and Hepatic fibrosis: Dai J et al. results (Dai et al., 2020) show that ATO stimulates PML small ubiquitin-like modifier SUMOylation through the activation of TGF-β/Smad signaling pathway, up-regulating the production of inflammatory factors and activation markers in HSCs, eventually promoting the induction of liver fibrosis.